During the past decade, National Hepatology and Tropical Medicine Research Institute conducted 22 clinical trials. In the 10-year time frame, 22 clinical trials started and 1 clinical trials were completed, i.e. on average, 4.5% percent of trials that started reached the finish line to date. In the past 5 years, 9 clinical trials started and 1 clinical trials were completed. i.e. 11.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hepatology and Tropical Medicine Research Institute" #1 sponsor was "National Hepatology & Tropical Medicine Research Institute" with 8 trials, followed by "Ain Shams University" with 3 trials sponsored, "Cairo University" with 3 trials sponsored, "ANRS, Emerging Infectious Diseases" with 2 trials sponsored and "French National Agency for Research on AIDS and Viral Hepatitis" with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hepatology and Tropical Medicine Research Institute" #1 collaborator was "National Hepatology & Tropical Medicine Research Institute" with 3 trials as a collaborator, "Hoffmann-La Roche" with 2 trials as a collaborator, "Institut Pasteur" with 2 trials as a collaborator, "Ain Shams University" with 1 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "National Hepatology and Tropical Medicine Research Institute" are "Chronic Hepatitis C" (3 trials), "Hepatitis C" (3 trials), "Carcinoma, Hepatocellular" (2 trials), "Non-Alcoholic Fatty Liver Disease" (2 trials) and "Advanced Hepatocellular Carcinoma" (1 trials). Many other conditions were trialed in "National Hepatology and Tropical Medicine Research Institute" in a lesser frequency.

Most popular intervention types in "National Hepatology and Tropical Medicine Research Institute" are "Drug" (18 trials), "Device" (2 trials), "Behavioral" (1 trials), "Diagnostic Test" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "pegylated interferon alpha2a" (2 trials), "Allopurinol (100 mg/day) plus lifestyle intervention" (1 trials), "Aspirin" (1 trials) and "BCAA preparation Intravenous infusion" (1 trials). Other intervention names were less common.

The vast majority of trials in "National Hepatology and Tropical Medicine Research Institute" are 26 trials for "All" genders.

Currently, there are NaN active trials in "National Hepatology and Tropical Medicine Research Institute". undefined are not yet recruiting, 6 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in National Hepatology and Tropical Medicine Research Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in National Hepatology and Tropical Medicine Research Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".

National Hepatology and Tropical Medicine Research Institute has several departments that took part in Clinical trials: "Al-Azhar University Faculty of Medicine" - 5 trials, "Ethics Committee - Alexandria Faculty of Medicine" - 2 trials